Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.5143 -0.0117 (-2.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase
Via ACCESSWIRE
News headline image
Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements
Via ACCESSWIRE
News headline image
Cosmos Health Successfully Completes Second Phase of CCX0722 Development, an Innovative Product for Obesity and Weight Management: Significant Step in Bringing Product to the Multi-Billion-Dollar Market
Via ACCESSWIRE
News headline image
Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million
Via ACCESSWIRE
News headline image
Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta
Via ACCESSWIRE
News headline image
A Look Into Cosmos Health's Debt ↗
Shares of Cosmos Health Inc. (NASDAQ:COSM) decreased by 64.91% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
News headline image
Cosmos Health set to join Russell Microcap Index
Via ACCESSWIRE
News headline image
Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately €32M, or 70%, by the End of 2025 vs FY 2022.
Via ACCESSWIRE
News headline image
Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income
Via ACCESSWIRE
News headline image
Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement
Via ACCESSWIRE
News headline image
Cosmos Health Advances Its Strategic Plan; Acquires Distressed Property Housing Operations of CosmoFarm, Expected to Generate Substantial Value for Shareholders
Via ACCESSWIRE
News headline image
Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022
Via ACCESSWIRE
News headline image
Insiders Buying Simply Good Foods And 2 Other Stocks ↗
Although US stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Cosmos Health Inc. to Participate in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, with CEO Mr. Greg Siokas Delivering a Speech
Via ACCESSWIRE
News headline image
Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc.
Via ACCESSWIRE
News headline image
Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters
Via ACCESSWIRE
News headline image
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
News headline image
Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories
Via ACCESSWIRE
News headline image
Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
News headline image
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests
Via ACCESSWIRE
BioMedNewsBreaks – Cosmos Health Inc. (NASDAQ: COSM) Begins Process for Upstream Dual Listing
Via Investor Brand Network
News headline image
Cosmos Health Announces Application for Dual Listing on Upstream
Via ACCESSWIRE
News headline image
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer
Via ACCESSWIRE
News headline image
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities
Via ACCESSWIRE
News headline image
Why Cosmos Health Shares Are Exploding Higher ↗
Cosmos Health Inc (NASDAQ: COSM) shares are trading higher by 19.43% to $5.84 Tuesday afternoon after the company announced a $3 million share repurchase program. 
Via Benzinga
News headline image
Cosmos Health Announces Stock Buyback Program
Via ACCESSWIRE
News headline image
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views ↗
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday. 
Via Benzinga
News headline image
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.